Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001641172-25-010853·Commodore Capital LP
Schedule 13G ownership disclosure
Relay Therapeutics Inc
Common Stock, par value $0.001 per share · CUSIP: 75943R102
Event date: 2025-05-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Commodore Capital LP
Shares: 10,000,000.00 · Class: 5.8%
- Commodore Capital Master LP
Shares: 10,000,000.00 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-010853
- Form type
- SCHEDULE 13G
- Filer
- Commodore Capital LP
- CIK
- CIK 1831942
- Filed
- May 15, 2025
- Reporting period
- May 08, 2025
- Description
- Schedule 13G beneficial ownership